Hbk Sorce Advisory LLC Novartis Ag Transaction History

Hbk Sorce Advisory LLC

$2.53 Billion
Q4 2024

A detailed history of Hbk Sorce Advisory LLC transactions in Novartis Ag stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 2,341 shares of NVS stock, worth $248,754. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,341

Previous 2,299 1.83%

Holding current value

$248,754

Previous $264,000 14.02%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$96.78 - $117.18 $4,064 - $4,921	42 Added 1.83%	2,341 $227,000
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $23,560 - $26,837	-222 Reduced 8.81%	2,299 $264,000
Q2 2024 Aug 08, 2024	BUY	$92.57 - $107.37 $13,330 - $15,461	144 Added 6.06%	2,521 $268,000
Q1 2024 May 09, 2024	SELL	$95.27 - $108.47 $5,906 - $6,725	-62 Reduced 2.54%	2,377 $229,000
Q4 2023 Jan 25, 2024	BUY	$92.27 - $101.54 $1,845 - $2,030	20 Added 0.83%	2,439 $246,000
Q3 2023 Nov 06, 2023	BUY	$94.73 - $105.13 $2,273 - $2,523	24 Added 1.0%	2,419 $246,000
Q2 2023 Aug 04, 2023	SELL	$92.52 - $104.91 $208,817 - $236,781	-2,257 Reduced 48.52%	2,395 $241,000
Q1 2023 Aug 15, 2023	SELL	$80.03 - $92.81 $4,881 - $5,661	-61 Reduced 2.55%	2,334 $214,000
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $10,884 - $12,622	-136 Reduced 2.84%	4,652 $650,000
Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $361,733 - $442,985	4,788 New	4,788 $434,000
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $186,806 - $217,500	-2,320 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $7,930 - $8,971	-99 Reduced 4.09%	2,320 $204,000
Q4 2021 Feb 15, 2022	SELL	$79.7 - $88.13 $247,468 - $273,643	-3,105 Reduced 56.21%	2,419 $212,000
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $1,799 - $2,093	-22 Reduced 0.4%	5,524 $452,000
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $16,110 - $17,794	-189 Reduced 3.3%	5,546 $506,000
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $23,213 - $27,374	278 Added 5.09%	5,735 $490,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $46,685 - $56,469	-598 Reduced 9.88%	5,457 $515,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $3,449 - $3,822	-42 Reduced 0.69%	6,055 $527,000
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $93,474 - $105,220	1,155 Added 23.37%	6,097 $533,000
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $40,847 - $57,227	578 Added 13.24%	4,942 $407,000
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $76,589 - $86,595	908 Added 26.27%	4,364 $413,000
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $64,839 - $71,449	758 Added 28.09%	3,456 $300,000
Q2 2019 Aug 15, 2019	BUY	$75.4 - $92.8 $203,429 - $250,374	2,698 New	2,698 $246,000
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $157,586 - $193,952	-2,090 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$75.32 - $86.15 $157,418 - $180,053	2,090 New	2,090 $201,000
Q3 2018 Nov 15, 2018	SELL	$66.94 - $77.43 $303,639 - $351,222	-4,536 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$64.91 - $73.36 $294,431 - $332,760	4,536 New	4,536 $0

Others Institutions Holding NVS

# of Institutions

1,439

Shares Held

135M

Call Options Held

1.12M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Account

Hbk Sorce Advisory LLC Novartis Ag Transaction History